Asymmetrex, LLC is an international stem cell biotechnology company headquartered in the U.S. The company’s U.S. and U.K. patented TORTOISE Test™ and RABBIT Count™ platforms are major accelerators of progress in stem cell medicine and pharmaceutical development. These kinetic stem cell counting platforms provide rapid determination of the specific dosage of therapeutic tissue stem cells, like HSCs and MSCs. The platforms also allow effective early identification of drug candidates with greater potential for successful development.
GenScript is a world-leading provider of cutting-edge technologies, unparalleled products, and renowned custom services that support life sciences research. Headquartered in New Jersey, with subsidiaries in Europe, Japan, and China, GenScript provides top research services to the global scientific community. Our extensive products portfolio ranges from validated antibodies, cytokines, stable cell lines, surface marker-based cell separation, protein purification magnetic beads, to PCR, gene cloning and gene editing reagents and kits.
We provide off-the-shelf reagents and kits that automate protein analysis processes such as PAGE gel staining, and western blotting. Our innovative magnetic purification technology provides reagents and instruments for automated recombinant protein purification (AmMagTM purification technology) and marker-assisted cell separation (CytoSinctTM cell separation technology). During the ongoing public health emergency generated by the COVID-19 pandemic, GenScript has stepped up and supported scientists and community leaders worldwide by developing key products such as SARS-CoV-2 qRT-PCR detection assays, viral gene-expressing stable cells lines, and more. GenScript’s cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit is the first FDA-EUA authorized kit that specifically detects virus-blocking antibodies in patients’ blood. With such groundbreaking new technologies and an unmitigated commitment to excellence, GenScript helps scientists all over the world accelerate their research.
Corporate venturing arm of Tosoh Corporation, focused on Bioprocess, In-Vitro Diagnostics, Lifescience Tools and Health/Disease Monitoring. Tosoh is a global comprehensive chemicals and specialty materials manufacturer. Tosoh’s consolidated net sales is US$7.2 billion in fiscal 2019. Our Bioscience products are represented by Bio-separation resin and column and GPC instruments for separation & purification business and automated immunoassay and glycohemoglobin analyzers for clinical diagnostics business. Looking for opportunities to work with companies with cutting-edge technologies.
Ecolab Life Sciences supports safety, compliance and operational efficiency for pharmaceutical and personal care manufacturers by delivering a comprehensive, programmatic approach and global expertise to contamination control, cleaning and disinfection. Our end-to-end solutions, enhanced by Bioquell technology, allow our customers to have safer products and processes by reducing their risks.
Crowell & Moring is an international law firm located in Brussels, Doha, London, Los Angeles, New York, Orange County, San Francisco, Shanghai, and Washington, D.C. We are recognized for providing innovative approaches to legal and business challenges, and creative alternative fee arrangements demonstrating our investment in achieving client objectives. With approximately 575 lawyers, we represent clients in complex high-stakes litigation, enforcement, regulatory and administrative, and transactional matters, as well as in government and internal investigations.
Greiner Bio-One ranks among the leading providers of specialized products for the cultivation and analysis of cell and tissue cultures.
We offer innovative multi-layer tissue culture solutions and triple packed products and continue to utilise our expertise in the development and production of microplates for high-throughput screening, thereby allowing extremely fast and efficient drug screening. Drawing on decades of experience with cryogenic sample storage, we also provide solutions for automated storage systems in biobanks.
cytena is a life-science company, focusing on single cell technologies and is part of the CELLINK Group. Cytena’s products improve efficiency across entire workflows for single-cell RNA sequencing, single-cell genome sequencing, single-cell proteomics, as well as the latest assays for single-cell multiomics. Most top ten pharmaceutical companies use cytena’s single-cell printers to produce clonal cell lines for manufacturing antibodies.
Solentim is the trusted global leader in workflows for antibody and cell-based therapies. Our assurance rich technologies enable the isolation, growth and characterization of high value cells while our data driven platform enables smarter decision earlier in the process. Together, our customers experience faster workflows, confidently designed for regulatory environments.
Namocell provides innovative single cell sorting and dispensing platforms to empower single cell research and development. Namocell’s Single Cell Dispensers are the fastest and easiest way to identify, isolate and dispense single cells by size or fluorescence, while being very gentle to the cells. We serve scientists in a wide range of applications, including cell line development, iPSC, CRISPR, single cell genomics, rare cell isolation, monoclonal antibody development, and synthetic biology. Learn more at www.namocell.com.
We aspire to accelerate the delivery of new medicines to patients through building partnerships with biotech and pharmaceutical companies around the world. Our mission is to continuously make it sure, secure, faster, and cheaper for therapeutic pharmaceutical companies to develop novel solutions.
Premas Biotech was founded in 2005 with the vision of transforming drug development. We have acquired in-depth expertise and built state-of-the-art technology platforms to provide quality products that are second to none.
Premas employs a world-class team of more than 150 dedicated scientists and managers, who have successfully developed over 650 molecules. By fostering an innovative and inclusive culture, we have created an ecosystem for establishing productive, long-term partnerships with our clients.
We aim to be problem-solvers for our customers, by actively listening and being accessible 24/7 wherever we are needed. We innovate based on our customers’ needs. Our organization has the flexibility to adapt the way we do business to what each customer needs, supporting the development activities for companies of all sizes.
